← All claims

Gut & Microbiome

peppermint oil treats irritable bowel syndrome

Leans support Gut & Microbiome 🔬 Includes disconfirming
RefutedContestedStrong support
consensus score 0.56

📅 Last reviewed: 2026-07-15

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

6 support 1 contradict 1 tested null 0 mixed · 8 sources, 7 independent groups

What the evidence shows

Enteric-coated peppermint oil reduces global IBS symptoms and abdominal pain.

The evidence (8)

SourceGradeStanceQualityFinding
Khanna
2014 · J Clin Gastroenterol
meta-analysis supports moderate MA: enteric-coated peppermint oil superior to placebo for IBS symptom improvement
Alammar
2019 · BMC Complement Altern Med
meta-analysis supports moderate Pooled MA: peppermint oil improved IBS global symptoms and abdominal pain vs placebo
Weerts ZZRM, et al.
2020 · Gastroenterology
RCT tested-null high Peppermint oil did NOT beat placebo on FDA/EMA primary responder endpoints (some secondary pain endpoints improved).
Ingrosso MR, et al.
2022 · Aliment Pharmacol Ther
meta-analysis supports moderate Enteric peppermint oil reduced global IBS symptoms and abdominal pain vs placebo.
Black
2020 · Lancet Gastroenterol Hepatol
meta-analysis supports moderate Network MA: peppermint oil ranked among efficacious traditional IBS therapies
Hirata M et al
2025 · study_type: meta-analysis
RCT supports moderate Systematic review, 16 Mentha clinical trials (IBS, functional dyspepsia, FAP), Cochrane RoB tool. Most studies reported significant benefit on abdominal pain/discomfort; 2 of the included trials found no superior outcome vs comparator.
Vermeijden NK et al
2026 · study_type: RCT
RCT contradicts high Dutch multicenter RCT, n=228 children 8-18y. Treatment success (>=30% pain reduction): peppermint oil 44.0% vs placebo 37.3% (OR 1.33, 97.5% CI 0.58-3.09, P=.44). Not superior to placebo.
Zeraattalab-Motlagh S et al
2025 · study_type: meta-analysis
meta-analysis supports low Umbrella review of 58 MAs/175 RCTs in adult IBS; peppermint oil (with soluble fiber, aloe vera) listed among interventions improving IBS symptoms, but GRADE certainty rated low-to-very-low overall.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.